// App-Quantinova.ai

: Survival Advantage to Allogeneic Transplant in Patients with Myelofibrosis with Intermediate-1 or Higher DIPSS Score

Researchers

Presenter

  • Krisstina L. Gowin

Principal Investigators

  • Kwang Woo Ahn

  • Zhen-Huan Hu

  • Ying Liu

  • Lucia Masarova

  • Srdan Verstovsek

  • Maria Coakley

  • Tania Jain

  • Andrew Kuykendall

  • Rami Komrokji

  • Martha Wadleigh

  • Sarah Patches

  • Murat Arcasoy

  • Michael Green

  • Malathi Kandarpa

  • Moshe Talpaz

  • Haris Ali

  • Vikas Gupta

  • Rebecca Devlin

  • Laura C. Michaelis

  • Gabriela S. Hobbs

  • Brady Lee Stein

  • Ashley Pariser

  • Aaron T. Gerds

  • Kierstin Kuber

  • Raajit Rampal

  • Edwin P. Alyea

  • Uday Popat

  • Ronald Sobecks

  • Bart L Scott

  • Ruben Mesa

  • Wael Saber

Medical Centers

  • Department of Hematology-Oncology, University of Arizona, Tucson, AZ

  • Hematology Oncology, University of Virginia, Charlottesville, VA

  • Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

  • Division of Biostatistics, Institution for Health and Society, Medical College of Wisconsin, Milwaukee, WI

  • Division of Biostatistics, Institution for Health and Society, Medical College of Wisconsin, Milwaukee, WI

  • Department of Genetics, UT MD Anderson Cancer Center, Houston, TX

  • Department of Radiology, MD Anderson Cancer Center, Houston, TX

  • Royal Marsden Hospital, Surrey, United Kingdom

  • Mayo Clinic Arizona, Phoenix, AZ

  • Moffitt Cancer Center, Tampa, FL

  • Moffitt Cancer Center, Houston, TX

  • Dana-Farber Cancer Institute, Boston, MA

  • Duke University Medical Center, Durham, NC

  • Rogel Cancer Center, The University of Michigan - Michigan Medicine, Ann Arbor, MI

  • University of Michigain Health System, Ann Arbor, MI

  • Department of pathology, City of Hope National Medical Center, Duarte, CA.

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Harvard University, Cambridge, MA

  • The Medical College of Wisconsin, Milwaukee, WI

  • Massachusetts General Hospital, Boston, MA

  • Dept. of Medicine, Division of Hematology/Oncology and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

  • Yale Cancer Center, New Haven, CT

  • Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

  • Washington University, St Louis, MO

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH

  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Locations

  • United States

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelofibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved